EFNS task force report: A questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres

European Journal of Neurology

Volumn 7, Issue 6, 2000, Pages 625-628

  Willison, H J ^a   Ang, W ^b   Gilhus, N E ^c   Graus, F ^d   Liblau, R ^e   Vedeler, C ^c   Vincent, A ^f  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d HOSPITAL CLÍNIC   (Spain)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Autoantibody; Neuroimmunology centres; Quality assurance; Service provision

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEALTH SURVEY; METHODOLOGY; MYASTHENIA GRAVIS; NEUROIMMUNOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; REVIEW;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; EUROPE; HEALTH CARE SURVEYS; HUMANS; IMMUNOASSAY; MYASTHENIA GRAVIS; NERVOUS SYSTEM DISEASES; PARANEOPLASTIC SYNDROMES; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RECEPTORS, CHOLINERGIC;

EID: 0034483128     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2000.00158.x     Document Type: Review

References (25)

1. Anti-Huassociated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients
2. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer
3. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration
4. Autoimmunity in paraneoplastic neurological syndromes
5. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease
6. Serum autoantibodies bind to voltage-gated potassium channels in acquired neuromyotonia
7. Anti-GD1a antibody distinguishes axonal from demyelinating forms of Guillain-Barré syndromes
8. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes
9. Paraneoplastic and oncologic profile of patients seropositive for type 1 antineuronal nuclear autoantibodies
10. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
11. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome
12. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome
13. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients
14. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity
15. Anti-amphiphysin I antibodies in patients with paraneoplastic neurologic disorders associated with small cell lung carcinoma
16. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome
17. Antibodies to ion channels in paraneoplastic disorders
18. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 1967 diagnostic assays
19. Autoimmunity in paraneoplastic neurological disorders
20. Pathogenic autoantibodies to neuronal proteins in neurological disorders
21. A serological marker for paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer
22. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinaemia
23. A somatically mutated human anti-ganglioside antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, Vl-18
24. Inter-laboratory validation of an ELISA for the determination of serum antiganglioside antibodies
25. A comparative trial of anti-glycoconjugate antibody asays: IgM antibodies to GM1